European Society of Cardiology

Improvements in exercise capacity and quality of life associated with aficamten coincided with significant cardiac remodeling and replacement fibrosis in patients with obstructive hypertrophic cardiomyopathy, a speaker reported.

In patients with persistent chylomicronemia, plozasiran, a small interfering RNA therapy, was associated with lower triglyceride levels and reduced risk for pancreatitis, researchers reported at the European Society of Cardiology Congress.

Women with obesity and atherosclerotic CVD without diabetes experience fewer CV events vs. men enrolled in the SELECT trial; however, semaglutide was linked to significant reductions in CV events regardless of sex, a speaker reported.

Hospital admissions for heart attack increased after exposure to lower air temperature and cold spells, researchers reported at the European Society of Cardiology Congress.

Catching up on sleep over the weekend was associated with lower likelihood of having heart disease compared with individuals who slept less than they would during the week, a speaker reported.

High- vs. standard-dose influenza vaccine was linked to a lower incidence of mortality and hospitalizations for pneumonia or influenza regardless of chronic CVD, according to a study presented at the European Society of Cardiology Congress.

Patients with atrial fibrillation needing stroke prevention assigned to abelacimab had very low rates of bleeding during invasive procedures, according to new data from the AZALEA-TIMI 71 trial.

For older adults with non-STEMI, routine coronary intervention was safe but did not lower risk for death from CV causes or nonfatal MI compared with medical therapy alone, according to new data from the SENIOR-RITA trial.

In patients with atrial fibrillation and heart failure with reduced ejection fraction, cryoballoon ablation was noninferior to radiofrequency ablation, according to the results of the CRABL-HF trial.

Mass ECG screening for atrial fibrillation in older adults did not reduce the incidence of stroke or stroke hospitalization, according to the results of two trials presented at the European Society of Cardiology Congress.